These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8308769

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
    Ohosone Y, Okano Y, Kameda H, Fujii T, Hama N, Hirakata M, Mimori T, Akizuki M, Ikeda Y.
    J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
    [Abstract] [Full Text] [Related]

  • 4. Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate.
    Carroll GJ, Thomas R, Phatouros CC, Atchison MH, Leslie AL, Cook NJ, D'Souza I.
    J Rheumatol; 1994 Jan; 21(1):51-4. PubMed ID: 8151587
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 11. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ, Esdaile JM, Klinkhoff AV, Grant E, Fitzgerald A, Canvin J, METGO Study Group.
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [Abstract] [Full Text] [Related]

  • 12. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR, Elliott JR, Mallek JA, Mikuls TR, Weaver CA, Glickstein S, Blakely KM, Hausch R, Leff RD.
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [Abstract] [Full Text] [Related]

  • 15. Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases.
    Sany J, Anaya JM, Lussiez V, Couret M, Combe B, Daures JP.
    J Rheumatol; 1991 Sep; 18(9):1323-7. PubMed ID: 1757932
    [Abstract] [Full Text] [Related]

  • 16. Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failure.
    Kapral T, Stamm T, Machold KP, Montag K, Smolen JS, Aletaha D.
    Arthritis Res Ther; 2006 Sep; 8(2):R46. PubMed ID: 16507172
    [Abstract] [Full Text] [Related]

  • 17. Pancytopenia associated with low dose methotrexate therapy. A regional survey.
    al-Awadhi A, Dale P, McKendry RJ.
    J Rheumatol; 1993 Jul; 20(7):1121-5. PubMed ID: 8371202
    [Abstract] [Full Text] [Related]

  • 18. Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients.
    McKendry RJ, Cyr M.
    Arch Intern Med; 1989 Mar; 149(3):685-9. PubMed ID: 2919941
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS.
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.